絕緣泡殼包裝藥品市場規模的有效選擇、按材料、應用和地區分類的佔有率和成長分析 - 行業預測 2025-2032

2023年全球冷藏泡殼包裝有效選擇藥品市場規模價值為37億美元，預計將從2024年的39.8億美元成長到2032年的70.9億美元，預測期內（2025-2032年）的複合年成長率為7.5%。

等溫泡殼包裝採用 Drybond 層壓技術生產，將鋁箔結合在聚氯乙烯(PVC) 和尼龍 (OPA) 薄膜之間，為您的產品提供額外的保護。這些包裝採用更厚的箔設計，可有效阻擋氧氣和濕氣，從而延長保存期限。然而，製造商面臨的挑戰包括與熱成型相比生產速度較慢，這會影響整個供應鏈的動態。包裝透明度問題和更大的泡殼卡進一步使市場情勢複雜化。儘管有這些缺點，但隨著醫療保健產業（尤其是藥品和醫療設備）的擴張，對冷藏泡殼包裝的需求仍在持續成長。可客製化的包裝功能（如推入式和兒童防護設計）可滿足各種治療需求，確保市場持續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 原料分析
• 監管分析

依材料及複合年成長率對冷泡殼包裝藥品市場規模進行有效選擇（2025-2032）

• 市場概況
• 鋁
• 定向聚醯胺
• 聚氯乙烯（PVC）
• 聚乙烯 (PE)
• 聚丙烯（PP）
• 聚對苯二甲酸乙二醇酯（PET）

依應用及複合年成長率有效選擇冷泡殼包裝藥品市場規模（2025-2032）

• 市場概況
• 藥品
• 電子和半導體
• 食物
• 消費品
• 其他

按地區和複合年成長率分類的冷泡殼包裝藥品市場規模的有效選擇（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Amcor Plc（Switzerland）
• Klockner Pentaplast（Germany）
• Sudpack（Germany）
• TekniPlex（USA）
• Constantia Flexibles（Austria）
• CCL Industries Inc.（Canada）
• UFlex Limited（India）
• Nelipak Healthcare Packaging（USA）
• Sonoco Products Company（USA）
• WestRock Company（USA）
• Honeywell International Inc.（USA）
• ACG Group（India）
• Gerresheimer AG（Germany）
• AptarGroup, Inc.（USA）
• West Pharmaceutical Services, Inc.（USA）
• WINPAK LTD.（Canada）
• SteriPack Group（Ireland）
• Blisterpak, Inc.（USA）
• Berry Global Group, Inc.（USA）
• Schott AG（Germany）

結論和建議

Global Cold Blister Packaging Effective Choice Pharmaceutical Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.98 billion in 2024 to USD 7.09 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

Cold form blister packs, produced using dry bond lamination technology, combine aluminum foil between polyvinyl chloride (PVC) and nylon (oPA) films for enhanced product protection. These packs effectively shield against oxygen and moisture, thereby extending shelf life with their thicker foil design. However, manufacturers face challenges such as slower production speeds compared to thermoforming, which affects the overall supply chain dynamics. Transparency issues with the packaging and the increasing size of blister cards further complicate the market landscape. Despite these drawbacks, the demand for cold form blister packaging continues to rise driven by the expanding healthcare sector, particularly in pharmaceuticals and medical devices. Customizable pack features, such as push-through and child-resistant designs, cater to various therapeutic needs, ensuring continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cold Blister Packaging Effective Choice Pharmaceutical market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cold Blister Packaging Effective Choice Pharmaceutical Market Segments Analysis

Global Cold Blister Packaging Effective Choice Pharmaceutical Market is segmented by Material, Application and region. Based on Material, the market is segmented into Aluminum, Oriented-polyamide, Polyvinyl Chloride (PVC), Polyethylene (PE), Polypropylene (PP) and Polyethylene Terephthalate (PET). Based on Application, the market is segmented into Pharmaceuticals, Electronics and Semiconductors, Foods, Consumer Goods and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cold Blister Packaging Effective Choice Pharmaceutical Market

The primary catalyst for growth in the Global Cold Blister Packaging market is the increasing adoption of blister packaging for tablets and capsules. This packaging method is widely utilized, as it allows individual capsules to be housed in larger cartons, effectively protecting the contents from contamination. The OPA/Al/PVC multilayer structure is the most prevalent material configuration used in the production of blister packs globally. Moreover, blister packs offer excellent protection against environmental factors, such as contamination and humidity, for extended durations. Consequently, the convenience and efficiency of cold blister packaging have greatly propelled its popularity within the pharmaceutical sector.

Restraints in the Global Cold Blister Packaging Effective Choice Pharmaceutical Market

The global cold blister packaging market faces several challenges that could restrain its growth in the pharmaceutical industry. One primary concern is the limited design versatility, which restricts options for shape, size, and branding. Pharmaceutical companies often struggle to distinguish their products in a competitive landscape due to the uniformity associated with cold-formed blisters. This lack of design flexibility can hinder effective branding and product visibility. Additionally, as environmental issues gain prominence, the extensive use of plastics in cold blister packaging raises sustainability concerns. The industry is increasingly urged to adopt eco-friendly practices, and the complexities surrounding the disposal and recycling of these materials may further conflict with the shift towards greener packaging solutions.

Market Trends of the Global Cold Blister Packaging Effective Choice Pharmaceutical Market

The Global Cold Blister Packaging market for pharmaceuticals is experiencing a robust growth trajectory, driven by the expansion of the generic drug sector and increasing financial investments in pharmaceutical R&D. The surge in e-commerce for marketing pharmaceutical products coupled with the rapid evolution of the drug delivery industry is reshaping market dynamics. Innovative packaging solutions, including oral ingestible containers, inhalers, and nasal sprays, are gaining traction, reflecting a shift towards improved convenience and sealing efficacy. Heightened consumer demand for diverse products and adherence to stricter environmental standards further propel the need for advanced packaging solutions in this sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis
• Regulatory Analysis

Global Cold Blister Packaging Effective Choice Pharmaceutical Market Size by Material & CAGR (2025-2032)

• Market Overview
• Aluminum
• Oriented-polyamide
• Polyvinyl Chloride (PVC)
• Polyethylene (PE)
• Polypropylene (PP)
• Polyethylene Terephthalate (PET)

Global Cold Blister Packaging Effective Choice Pharmaceutical Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Electronics and Semiconductors
• Foods
• Consumer Goods
• Others

Global Cold Blister Packaging Effective Choice Pharmaceutical Market Size & CAGR (2025-2032)

• North America (Material, Application)
  • US
  • Canada
• Europe (Material, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Amcor Plc (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Klockner Pentaplast (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sudpack (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TekniPlex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Constantia Flexibles (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CCL Industries Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UFlex Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nelipak Healthcare Packaging (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonoco Products Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WestRock Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Honeywell International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACG Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WINPAK LTD. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SteriPack Group (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blisterpak, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berry Global Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schott AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations